Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.
Saved in:
| Title: | Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. |
|---|---|
| Authors: | Pinato DJ; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., D'Alessio A; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Fulgenzi CAM; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom., Schlaak AE; Department of Internal Medicine, University Hospital Freiburg, Freiburg, Germany., Celsa C; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Palermo, Italy., Killmer S; Department of Internal Medicine, University Hospital Freiburg, Freiburg, Germany., Blanco JM; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, St Mary's Hospital Campus, London, United Kingdom., Ward C; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom., Stikas CV; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom., Openshaw MR; Institute of Cancer and Genomics Sciences, University of Birmingham, Birmingham, United Kingdom., Acuti N; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom., Nteliopoulos G; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom., Balcells C; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom., Keun HC; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom., Goldin RD; Centre for Pathology, Imperial College London, Charing Cross Hospital, London, United Kingdom., Ross PJ; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; King's College Hospital NHS Foundation Trust, London, United Kingdom., Cortellini A; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy., Thomas R; Interventional Radiology, Imperial College NHS Trust, Hammersmith Hospital, London, United Kingdom., Young AM; Department of Medical Oncology, St Georges University Hospitals, NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust, London, United Kingdom., Danckert N; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, St Mary's Hospital Campus, London, United Kingdom., Tait P; Interventional Radiology, Imperial College NHS Trust, Hammersmith Hospital, London, United Kingdom., Marchesi JR; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, St Mary's Hospital Campus, London, United Kingdom., Bengsch B; Department of Internal Medicine, University Hospital Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany, partner site Freiburg., Sharma R; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2433-2443. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Multicenter Study |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38578610 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pinato+DJ%22">Pinato DJ</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.<br /><searchLink fieldCode="AU" term="%22D'Alessio+A%22">D'Alessio A</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.<br /><searchLink fieldCode="AU" term="%22Fulgenzi+CAM%22">Fulgenzi CAM</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Schlaak+AE%22">Schlaak AE</searchLink>; Department of Internal Medicine, University Hospital Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Celsa+C%22">Celsa C</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Killmer+S%22">Killmer S</searchLink>; Department of Internal Medicine, University Hospital Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Blanco+JM%22">Blanco JM</searchLink>; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, St Mary's Hospital Campus, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ward+C%22">Ward C</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Stikas+CV%22">Stikas CV</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Openshaw+MR%22">Openshaw MR</searchLink>; Institute of Cancer and Genomics Sciences, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Acuti+N%22">Acuti N</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Nteliopoulos+G%22">Nteliopoulos G</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Balcells+C%22">Balcells C</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Keun+HC%22">Keun HC</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Goldin+RD%22">Goldin RD</searchLink>; Centre for Pathology, Imperial College London, Charing Cross Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ross+PJ%22">Ross PJ</searchLink>; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; King's College Hospital NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cortellini+A%22">Cortellini A</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.; Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Thomas+R%22">Thomas R</searchLink>; Interventional Radiology, Imperial College NHS Trust, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Young+AM%22">Young AM</searchLink>; Department of Medical Oncology, St Georges University Hospitals, NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Danckert+N%22">Danckert N</searchLink>; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, St Mary's Hospital Campus, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tait+P%22">Tait P</searchLink>; Interventional Radiology, Imperial College NHS Trust, Hammersmith Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Marchesi+JR%22">Marchesi JR</searchLink>; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, St Mary's Hospital Campus, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bengsch+B%22">Bengsch B</searchLink>; Department of Internal Medicine, University Hospital Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany, partner site Freiburg.<br /><searchLink fieldCode="AU" term="%22Sharma+R%22">Sharma R</searchLink>; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2433-2443. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38578610 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-24-0177 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2433 Titles: – TitleFull: Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pinato DJ – PersonEntity: Name: NameFull: D'Alessio A – PersonEntity: Name: NameFull: Fulgenzi CAM – PersonEntity: Name: NameFull: Schlaak AE – PersonEntity: Name: NameFull: Celsa C – PersonEntity: Name: NameFull: Killmer S – PersonEntity: Name: NameFull: Blanco JM – PersonEntity: Name: NameFull: Ward C – PersonEntity: Name: NameFull: Stikas CV – PersonEntity: Name: NameFull: Openshaw MR – PersonEntity: Name: NameFull: Acuti N – PersonEntity: Name: NameFull: Nteliopoulos G – PersonEntity: Name: NameFull: Balcells C – PersonEntity: Name: NameFull: Keun HC – PersonEntity: Name: NameFull: Goldin RD – PersonEntity: Name: NameFull: Ross PJ – PersonEntity: Name: NameFull: Cortellini A – PersonEntity: Name: NameFull: Thomas R – PersonEntity: Name: NameFull: Young AM – PersonEntity: Name: NameFull: Danckert N – PersonEntity: Name: NameFull: Tait P – PersonEntity: Name: NameFull: Marchesi JR – PersonEntity: Name: NameFull: Bengsch B – PersonEntity: Name: NameFull: Sharma R IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2024 Jun 03 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1557-3265 Numbering: – Type: volume Value: 30 – Type: issue Value: 11 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |